3002.13.00.10/Pembrolizumab Monoclonal Antibody/Japan

Pembrolizumab Monoclonal Antibody from Japan

Pembrolizumab (Keytruda) is a humanized IgG4 monoclonal antibody blocking PD-1 for immunotherapy in melanoma and lung cancer. HTS 3002.13.0010 for unmixed biotech monoclonal antibodies regulating immunology. Supplied in bulk, non-retail.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Align with FDA's RPDR for real-time import status tracking

• Include ADCC assay data for potency verification